A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors
Clinical trial NCT02165215 · COMPLETED
Trial details
- NCT number
- NCT02165215
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-12
- Primary completion
- 2020-04-06
- Enrollment
- 359
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.